Index
1 Market Overview of Molecular Diagnostics in Infectious Disease Testing
1.1 Molecular Diagnostics in Infectious Disease Testing Market Overview
1.1.1 Molecular Diagnostics in Infectious Disease Testing Product Scope
1.1.2 Molecular Diagnostics in Infectious Disease Testing Market Status and Outlook
1.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2018-2029)
1.4 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Region (2018-2023)
1.5 Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2029)
1.6.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2029)
1.6.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2029)
1.6.4 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2029)
2 Molecular Diagnostics in Infectious Disease Testing Market by Type
2.1 Introduction
2.1.1 Polymerase Chain Reaction (PCR)
2.1.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
2.1.3 Microarrays
2.1.4 Next-Generation Sequencing (NGS)
2.1.5 Hybridization
2.1.6 Others
2.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Type (2018-2029)
3 Molecular Diagnostics in Infectious Disease Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Academic Institutes
3.1.4 Laboratories
3.1.5 Others
3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
4 Molecular Diagnostics in Infectious Disease Testing Competition Analysis by Players
4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2022)
4.3 Date of Key Players Enter into Molecular Diagnostics in Infectious Disease Testing Market
4.4 Global Top Players Molecular Diagnostics in Infectious Disease Testing Headquarters and Area Served
4.5 Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Molecular Diagnostics in Infectious Disease Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.1.4 Abbott Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 BD
5.2.1 BD Profile
5.2.2 BD Main Business
5.2.3 BD Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.2.4 BD Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.2.5 BD Recent Developments
5.3 BioMerieux
5.3.1 BioMerieux Profile
5.3.2 BioMerieux Main Business
5.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.3.4 BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific Recent Developments
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Profile
5.4.2 Thermo Fisher Scientific Main Business
5.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.5.4 Roche Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 Siemens
5.6.1 Siemens Profile
5.6.2 Siemens Main Business
5.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.6.4 Siemens Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Siemens Recent Developments
5.7 Veridex
5.7.1 Veridex Profile
5.7.2 Veridex Main Business
5.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.7.4 Veridex Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Veridex Recent Developments
5.8 Luminex
5.8.1 Luminex Profile
5.8.2 Luminex Main Business
5.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.8.4 Luminex Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Luminex Recent Developments
5.9 GenMark Diagnostics
5.9.1 GenMark Diagnostics Profile
5.9.2 GenMark Diagnostics Main Business
5.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.9.4 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.9.5 GenMark Diagnostics Recent Developments
5.10 Qiagen
5.10.1 Qiagen Profile
5.10.2 Qiagen Main Business
5.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.10.4 Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Qiagen Recent Developments
5.11 Genomix Biotech
5.11.1 Genomix Biotech Profile
5.11.2 Genomix Biotech Main Business
5.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.11.4 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Genomix Biotech Recent Developments
5.12 BioTheranostics
5.12.1 BioTheranostics Profile
5.12.2 BioTheranostics Main Business
5.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.12.4 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.12.5 BioTheranostics Recent Developments
6 North America
6.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Molecular Diagnostics in Infectious Disease Testing Market Dynamics
11.1 Molecular Diagnostics in Infectious Disease Testing Industry Trends
11.2 Molecular Diagnostics in Infectious Disease Testing Market Drivers
11.3 Molecular Diagnostics in Infectious Disease Testing Market Challenges
11.4 Molecular Diagnostics in Infectious Disease Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List